Perbedaan Sumi Indo Kabel Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Sumi Indo Kabel Tbk. diperdagangkan di Rp565 (kapitalisasi pasar 679,32 M, volume 24 jam 83,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Sumi Indo Kabel Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Sumi Indo Kabel Tbk. lebih aktif diperdagangkan (83,5 rb vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IKBI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 679,32 M | 167,37 M |
Volume | 83,5 rb | 71 rb |
Lot | 835 | 710 |
Perputaran | 47,29 jt | 17,51 jt |
Harga Rata-rata | 566,29 | 246,63 |
Nilai Transaksi | 47,29 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 560 | 246 |
Volume Ekuilibrium Indikatif | 1 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.
Selengkapnya di halaman IKBI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →